table of content
1 Introduction to Research & Analysis Reports
1.1 Adipose Tissue-derived Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adipose Tissue-derived Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adipose Tissue-derived Stem Cell Therapy Overall Market Size
2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size: 2022 VS 2030
2.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adipose Tissue-derived Stem Cell Therapy Players in Global Market
3.2 Top Global Adipose Tissue-derived Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Adipose Tissue-derived Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adipose Tissue-derived Stem Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adipose Tissue-derived Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adipose Tissue-derived Stem Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Adipose Tissue-derived Stem Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Adipose Tissue-derived Stem Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Adipose Tissue-derived Stem Cell Therapy Market Size Markets, 2022 & 2030
4.1.2 Autologous Stem Cells
4.1.3 Allogeneic Stem Cells
4.2 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2024-2030
4.2.3 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adipose Tissue-derived Stem Cell Therapy Market Size, 2022 & 2030
5.1.2 Therapeutic Application
5.1.3 Research Application
5.2 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2024-2030
5.2.3 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Adipose Tissue-derived Stem Cell Therapy Market Size, 2022 & 2030
6.2 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2024-2030
6.2.3 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2030
6.3.2 US Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.3.3 Canada Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.3.4 Mexico Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2030
6.4.2 Germany Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.4.3 France Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.4.4 U.K. Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.4.5 Italy Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.4.6 Russia Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.4.8 Benelux Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2030
6.5.2 China Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.5.3 Japan Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.5.4 South Korea Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.5.6 India Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2030
6.6.2 Brazil Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.6.3 Argentina Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue, 2018-2030
6.7.2 Turkey Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.7.3 Israel Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
6.7.5 UAE Adipose Tissue-derived Stem Cell Therapy Market Size, 2018-2030
7 Adipose Tissue-derived Stem Cell Therapy Companies Profiles
7.1 AlloCure
7.1.1 AlloCure Company Summary
7.1.2 AlloCure Business Overview
7.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.1.4 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 AlloCure Key News & Latest Developments
7.2 Antria
7.2.1 Antria Company Summary
7.2.2 Antria Business Overview
7.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.2.4 Antria Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Antria Key News & Latest Developments
7.3 Celgene Corporation
7.3.1 Celgene Corporation Company Summary
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.3.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Celgene Corporation Key News & Latest Developments
7.4 Cellleris
7.4.1 Cellleris Company Summary
7.4.2 Cellleris Business Overview
7.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.4.4 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Cellleris Key News & Latest Developments
7.5 Corestem
7.5.1 Corestem Company Summary
7.5.2 Corestem Business Overview
7.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.5.4 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Corestem Key News & Latest Developments
7.6 Cytori Therapeutics
7.6.1 Cytori Therapeutics Company Summary
7.6.2 Cytori Therapeutics Business Overview
7.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.6.4 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Cytori Therapeutics Key News & Latest Developments
7.7 Intrexon
7.7.1 Intrexon Company Summary
7.7.2 Intrexon Business Overview
7.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.7.4 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Intrexon Key News & Latest Developments
7.8 Mesoblast
7.8.1 Mesoblast Company Summary
7.8.2 Mesoblast Business Overview
7.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.8.4 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Mesoblast Key News & Latest Developments
7.9 Pluristem Therapeutics
7.9.1 Pluristem Therapeutics Company Summary
7.9.2 Pluristem Therapeutics Business Overview
7.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.9.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Pluristem Therapeutics Key News & Latest Developments
7.10 Tissue Genesis
7.10.1 Tissue Genesis Company Summary
7.10.2 Tissue Genesis Business Overview
7.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.10.4 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Tissue Genesis Key News & Latest Developments
7.11 BioRestorative Therapies
7.11.1 BioRestorative Therapies Company Summary
7.11.2 BioRestorative Therapies Business Overview
7.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.11.4 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 BioRestorative Therapies Key News & Latest Developments
7.12 Celltex Therapeutics Corporation
7.12.1 Celltex Therapeutics Corporation Company Summary
7.12.2 Celltex Therapeutics Corporation Business Overview
7.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.12.4 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Celltex Therapeutics Corporation Key News & Latest Developments
7.13 iXCells Biotechnologies
7.13.1 iXCells Biotechnologies Company Summary
7.13.2 iXCells Biotechnologies Business Overview
7.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.13.4 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 iXCells Biotechnologies Key News & Latest Developments
7.14 Pluristem Therapeutics
7.14.1 Pluristem Therapeutics Company Summary
7.14.2 Pluristem Therapeutics Business Overview
7.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.14.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Pluristem Therapeutics Key News & Latest Developments
7.15 Cyagen
7.15.1 Cyagen Company Summary
7.15.2 Cyagen Business Overview
7.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.15.4 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.15.5 Cyagen Key News & Latest Developments
7.16 Lonza
7.16.1 Lonza Company Summary
7.16.2 Lonza Business Overview
7.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
7.16.4 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.16.5 Lonza Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
